Medicare, the federal health insurance program designed to serve individuals aged 65 and older, faces substantial financial challenges that are growing increasingly severe. Recently, a spotlight has been placed on the potential repercussions of including semaglutide, a high-cost medication
Johnson & Johnson (J&J), one of the leading pharmaceutical companies globally, has announced significant changes to its participation in the 340B drug discount program. Effective October 15, the company will cease providing upfront discounts on two key drugs and move to a rebate system
Healthtech is revolutionizing the healthcare industry, bringing advancements such as telemedicine, wearable devices, artificial intelligence (AI), and robotic-assisted surgery (RAS) into everyday practice. These technologies promise improved patient outcomes and more efficient healthcare delivery,
Advancements in health technology over the past decade have revolutionized healthcare delivery across the globe. This article delves into the effects of healthtech on medical malpractice claims, focusing on two distinct regions: Canada and Chile. With innovations like telemedicine, AI, wearables,
In the throes of recovery from the global pandemic, the senior living and care sector is encountering a resurgence of regulatory scrutiny. Nowhere is this truer than in skilled nursing facilities (SNFs), where compliance with state and federal mandates poses a formidable challenge. The tech startup
The Rise of Telehealth Coverage In the landscape of U.S. healthcare, one of the most significant transformations has been the evolution of telehealth legislation. Prior to the unforeseen circumstances of the COVID-19 pandemic in 2019, telehealth was positioned on the fringes of mainstream medical
